The effects of darifenacin and tolterodine on heart rate (HR) in patients with overactive bladder (OAB)

被引：0

作者：

Olshansky, B.

Foote, J.

Arguinzoniz, M.

Lheritier, K.

Quebe-Fehling, E.

Steel, M.

机构：

[1] Univ Iowa Hosp, Iowa City, IA USA

[2] Midtown Urol & Surg Ctr, Atlanta, GA USA

[3] Novartis Pharma AG, Basel, Switzerland

来源：

NEUROUROLOGY AND URODYNAMICS | 2006年 / 25卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

124

引用

页码：656 / 657

页数：2

共 50 条

[31] Overactive Bladder (OAB) Symptoms in Patients Undergoing Flexible Cystoscopy
Khan, Rafiullah
Nazim, Syed M.
Iqbal, Shahid
CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
[32] Assessment of Cardiovascular (CV) Comorbidity in Patients with Overactive Bladder (OAB)
Kim, JaeWhan
Asche, Carl
Kahler, Kristijian
Kulkarni, Amit
Andersson, Karl-Eric
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S241 - S242
[33] Analysis of heart rate variability in female patients with overactive bladder
Choi, JB
Kim, YB
Kim, BT
Kim, YS
UROLOGY, 2005, 65 (06) : 1109 - 1112
[34] Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin
Kay, G. G.
Ebinger, U.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2008, 62 (11) : 1792 - 1800
[35] PATIENTS' EXPERIENCE WITH DARIFENACIN: RESULTS OF A COMMUNITY-BASED SURVEY IN OVERACTIVE BLADDER PATIENTS
Newman, Diane
Green, L.
NEUROUROLOGY AND URODYNAMICS, 2010, 29 (02) : 295 - 295
[36] Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms
Herschorn, Sender
Heesakkers, John
Castro-Diaz, David
Wang, Joseph T.
Brodsky, Marina
Guan, Zhonghong
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (12) : 3513 - 3521
[37] Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia
Rackley, R
Weiss, JP
Rovner, ES
Wang, JT
Guan, ZH
UROLOGY, 2006, 67 (04) : 731 - 736
[38] Nighttime dosing of tolterodine reduces overactive bladder-related nocturnal frequency in patients with overactive bladder and nocturia
EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (03) : 62 - 62
[39] Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder
Jacquetin, B
Wyndaele, JJ
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 98 (01): : 97 - 102
[40] A COST-COMPARISON ANALYSIS OF TREATING OVERACTIVE BLADDER (OAB) WITH FESOTERODINE, TOLTERODINE OR SOLIFENACIN IN DAILY CLINICAL PRACTICE IN SPAIN
Sicras-Mainar, A.
Rejas, J.
Navarro-Artieda, R.
Aguado-Jodar, A.
Ruiz-Torrejon, A.
Kvasz, M. G.
VALUE IN HEALTH, 2012, 15 (07) : A455 - A455

← 1 2 3 4 5 →